Your browser doesn't support javascript.
loading
Nanoparticles for cancer therapy: a review of influencing factors and evaluation methods for biosafety.
Li, Jinghua; Wu, Tao; Li, Shiman; Chen, Xinyan; Deng, Zhiming; Huang, Yong.
Afiliação
  • Li J; State Key Laboratory of Targeting Oncology, National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, 530021, China.
  • Wu T; The First People's Hospital of Changde City, Changde, 415000, China.
  • Li S; School of Preclinical Medicine, Guangxi Medical University, Nanning, 530021, China.
  • Chen X; Key Laboratory of Clinical Laboratory Medicine of Guangxi, Department of Education, Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
  • Deng Z; The First People's Hospital of Changde City, Changde, 415000, China.
  • Huang Y; State Key Laboratory of Targeting Oncology, National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Guangxi Medical University, Nanning, 530021, China. huangyong503@126.com.
Clin Transl Oncol ; 25(7): 2043-2055, 2023 Jul.
Article em En | MEDLINE | ID: mdl-36807057

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China